Synthesis 2012; 44(20): 3216-3224
DOI: 10.1055/s-0032-1317145
paper
© Georg Thieme Verlag Stuttgart · New York

Palladium-Catalyzed Synthesis of Substituted Pyrido[2,3-d]pyridazines at Positions 5 and 8

Mohamed A. Ibrahim
a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
c   Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig-44519, Egypt
d   Department of Organic Chemistry, Misr University for Science and Technology, Al-Motamayez District, P.O. Box 77, 6th of October City, Egypt
,
Emilie Blaise
a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
,
Olivier Lozach
b   Station Biologique de Roscoff, CNRS – USR3151, Place G. Teissier, 29680 Roscoff, France
,
Claude Szalata
a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
,
Martine Schmitt
a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
,
Abd-Allah. S. El-Etrawy
d   Department of Organic Chemistry, Misr University for Science and Technology, Al-Motamayez District, P.O. Box 77, 6th of October City, Egypt
,
Mohamed Elagawany
a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
d   Department of Organic Chemistry, Misr University for Science and Technology, Al-Motamayez District, P.O. Box 77, 6th of October City, Egypt
,
Said A. El-Feky
c   Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig-44519, Egypt
,
Zakaria K. Abdel-Samii
c   Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig-44519, Egypt
,
Laurent Meijer
b   Station Biologique de Roscoff, CNRS – USR3151, Place G. Teissier, 29680 Roscoff, France
,
Jean-Jacques Bourguignon
a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
,
Frédéric Bihel*
a   Laboratoire d’Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 Route du Rhin, 67400 Illkirch Graffenstaden, France, Fax: +33(3)68854310   Email: fbihel@unistra.fr
› Author Affiliations
Further Information

Publication History

Received: 22 June 2012

Accepted after revision: 27 July 2012

Publication Date:
31 August 2012 (online)


Abstract

Several synthetic strategies were developed for the preparation of highly substituted pyrido[2,3-d]pyridazines. We particularly focused on the impact of the pyridine nitrogen atom on pyridazine ring reactivity toward aromatic substitutions, alkylations, or pallado-catalyzed cross-coupling reactions.

Supporting Information

 
  • References


    • For selected examples, see:
    • 1a Tao M, Raddatz R, Aimone LD, Hudkins RL. Bioorg. Med. Chem. Lett. 2011; 21: 6126
    • 1b Sridhara AM, Reddy KR. V, Keshavayya J, Goud PS. K, Somashekar BC, Bose P, Peethambar SK, Gaddam SK. Eur. J. Med. Chem. 2010; 45: 4983
    • 1c Alla MS. M. A, Hegab MI, Taleb NA. A, Hasabelnaby SM, Goudah A. Eur. J. Med. Chem. 2010; 45: 1267
    • 1d Khalil AM, Berghot MA, Gouda MA. Eur. J. Med. Chem. 2009; 44: 4448
    • 1e Cashman JR, Voelker T, Zhang HT, O’Donnell JM. J. Med. Chem. 2009; 52: 1530
    • 1f Vina D, del Olmo E, Lopez-Perez JL, Feliciano AS. Tetrahedron 2009; 65: 1574
    • 1g Menear KA, Adcock C, Boulter R, Cockcroft XL, Copsey L, Cranston A, Dillon KJ, Drzewiecki J, Garman S, Gomez S, Javaid H, Kerrigan F, Knights C, Lau A, Loh VM, Matthews IT. W, Moore S, O’Connor MJ, Smith GC. M, Martin NM. B. J. Med. Chem. 2008; 51: 6581
    • 1h Strappaghetti G, Brodi C, Giannaccini G, Betti L. Bioorg. Med. Chem. Lett. 2006; 16: 2575
    • 1i Cockcroft XL, Dillon KJ, Dixon L, Drzewiecki J, Kerrigan F, Loh VM, Martin NM. B, Menear KA, Smith GC. M. Bioorg. Med. Chem. Lett. 2006; 16: 1040
    • 1j Piatnitski EL, Duncton MA. J, Kiselyov AS, Katoch-Rouse R, Sherman D, Milligan DL, Balagtas C, Wong WC, Kawakami J, Doody JF. Bioorg. Med. Chem. Lett. 2005; 15: 4696
    • 1k Loh VM, Cockcroft XL, Dillon KJ, Dixon L, Drzewiecki J, Everlsey PJ, Gomez S, Hoare J, Kerrigan F, Matthews IT. W, Menear KA, Martin NM. B, Newton RF, Paul J, Smith GC. M, Vile J, Whittle AJ. Bioorg. Med. Chem. Lett. 2005; 15: 2235
    • 1l Kaminskas LM, Pyke SM, Burcham PC. Org. Biomol. Chem. 2004; 2: 2578
  • 2 Pakulska W, Malinowskl Z, Szczesniak AK, Czarnecka E, Epsztajn J. Arch. Pharmacol. 2009; 342: 41
  • 3 Kaizerman JA, Aaron W, An SZ, Austin R, Brown M, Chong A, Huang T, Hungate R, Jiang B, Johnson MG, Lee G, Lucas BS, Orf J, Rong MQ, Toteva MM, Wickramasinghe D, Xu GF, Ye QP, Zhong WD, McMinn DL. Bioorg. Med. Chem. Lett. 2010; 20: 4607
  • 4 For a review, see: Katritzky AR, Rachwal S, Rachwal B. Tetrahedron 1996; 52: 15031
  • 5 Meijer L, Flajolet M, Greengard P. Trends Pharmacol. Sci. 2004; 25: 471
  • 6 Knockaert M, Greengard P, Meijer L. Trends Pharmacol. Sci. 2002; 23: 417
  • 7 Knippschild U, Gocht A, Wolff S, Huber N, Lohler J, Stoter M. Cell Signal. 2005; 17: 675
  • 8 Ryoo SR, Jeong HK, Radnaabazar C, Yoo JJ, Cho HJ, Lee HW, Kim IS, Cheon YH, Ahn YS, Chung SH, Song WJ. J. Biol. Chem. 2007; 282: 34850